StockWatch
·

Tatva Chintan Pharma Chem Ltd Q3 FY25 Results

TATVAQ3 FY25 Results
Filing
MetricValue ( Cr)vs Q2 FY25
Revenue85.902.9%
Total Income85.942.5%
Expenditure86.171.5%
PBT-0.2377.0%
Net Profit0.14120.9%
OPM-8.87%
NPM0.16%
EPS0.06300.0%
View full financials

Informational and educational content only. Not investment advice.